This research study is studying the RGI-2001 for preventing Graft-vs-Host Disease (GVHD) in
people with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic
syndrome (MDS), myeloproliferative disorders (MPN), chronic myelomonocytic leukemic (CMML),
chemosensitive hodgkin lymphoma (HL), or Non-Hodgkin lymphoma (NHL).who will have a blood
stem cell transplantation.
- GVHD is a condition in which cells from the donor's tissue attack the organs.
- RGI-2001 is an investigational treatment